ELI LILLY: RETATRUTIDE DELIVERED GREATER IMPROVEMENTS THAN OZEMPIC ACROSS CERTAIN CARDIOVASCULAR RISK FACTORS IN TRIAL

Reuters · 3d ago

Please log in to view news